Association of the T allele of an intronic single nucleotide polymorphism in the colony stimulating factor 1 receptor with Crohn's disease: a case-control study
Background Polymorphisms in several genes (NOD2, MDR1, SLC22A4) have been associated with susceptibility to Crohn's disease. Identification of the remaining Crohn's susceptibility genes is essential for the development of disease-specific targets for immunotherapy. Using gene expression analysis, we identified a differentially expressed gene on 5q33, the colony stimulating factor 1 receptor (CSF1R) gene, and hypothesized that it is a Crohn's susceptibility gene. The CSF1R gene is involved in monocyte to macrophage differentiation and in innate immunity. Methods Patients provided informed consent prior to entry into the study as approved by the Institutional Review Board at LSU Health Sciences Center. We performed forward and reverse sequencing of genomic DNA from 111 unrelated patients with Crohn's disease and 108 controls. We also stained paraffin-embedded, ileal and colonic tissue sections from patients with Crohn's disease and controls with a polyclonal antibody raised against the human CSF1R protein. Results A single nucleotide polymorphism (A2033T) near a Runx1 binding site in the eleventh intron of the colony stimulating factor 1 receptor was identified. The T allele of this single nucleotide polymorphism occurred in 27% of patients with Crohn's disease but in only 13% of controls ($ X^{2} $ = 6.74, p < 0.01, odds ratio (O.R.) = 2.49, 1.23 < O.R. < 5.01). Using immunohistochemistry, positive staining with a polyclonal antibody to CSF1R was observed in the superficial epithelium of ileal and colonic tissue sections. Conclusions We conclude that the colony stimulating factor receptor 1 gene may be a susceptibility gene for Crohn's disease..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2004 |
---|---|
Erschienen: |
2004 |
Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
---|---|
Enthalten in: |
Journal of immune based therapies and vaccines - 2(2004), 1 vom: 14. Mai |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zapata-Velandia, Adriana [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Intronic Single Nucleotide Polymorphism |
---|
Anmerkungen: |
© Zapata-Velandia et al; licensee BioMed Central Ltd. 2004. This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. |
---|
doi: |
10.1186/1476-8518-2-6 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR029446031 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR029446031 | ||
003 | DE-627 | ||
005 | 20230519123822.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201007s2004 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/1476-8518-2-6 |2 doi | |
035 | |a (DE-627)SPR029446031 | ||
035 | |a (SPR)1476-8518-2-6-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zapata-Velandia, Adriana |e verfasserin |4 aut | |
245 | 1 | 0 | |a Association of the T allele of an intronic single nucleotide polymorphism in the colony stimulating factor 1 receptor with Crohn's disease: a case-control study |
264 | 1 | |c 2004 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © Zapata-Velandia et al; licensee BioMed Central Ltd. 2004. This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. | ||
520 | |a Background Polymorphisms in several genes (NOD2, MDR1, SLC22A4) have been associated with susceptibility to Crohn's disease. Identification of the remaining Crohn's susceptibility genes is essential for the development of disease-specific targets for immunotherapy. Using gene expression analysis, we identified a differentially expressed gene on 5q33, the colony stimulating factor 1 receptor (CSF1R) gene, and hypothesized that it is a Crohn's susceptibility gene. The CSF1R gene is involved in monocyte to macrophage differentiation and in innate immunity. Methods Patients provided informed consent prior to entry into the study as approved by the Institutional Review Board at LSU Health Sciences Center. We performed forward and reverse sequencing of genomic DNA from 111 unrelated patients with Crohn's disease and 108 controls. We also stained paraffin-embedded, ileal and colonic tissue sections from patients with Crohn's disease and controls with a polyclonal antibody raised against the human CSF1R protein. Results A single nucleotide polymorphism (A2033T) near a Runx1 binding site in the eleventh intron of the colony stimulating factor 1 receptor was identified. The T allele of this single nucleotide polymorphism occurred in 27% of patients with Crohn's disease but in only 13% of controls ($ X^{2} $ = 6.74, p < 0.01, odds ratio (O.R.) = 2.49, 1.23 < O.R. < 5.01). Using immunohistochemistry, positive staining with a polyclonal antibody to CSF1R was observed in the superficial epithelium of ileal and colonic tissue sections. Conclusions We conclude that the colony stimulating factor receptor 1 gene may be a susceptibility gene for Crohn's disease. | ||
650 | 4 | |a Single Nucleotide Polymorphism |7 (dpeaa)DE-He213 | |
650 | 4 | |a Superficial Epithelium |7 (dpeaa)DE-He213 | |
650 | 4 | |a Intronic Single Nucleotide Polymorphism |7 (dpeaa)DE-He213 | |
650 | 4 | |a Runx1 Binding Site |7 (dpeaa)DE-He213 | |
650 | 4 | |a NOD2 Polymorphism |7 (dpeaa)DE-He213 | |
700 | 1 | |a Ng, San-San |4 aut | |
700 | 1 | |a Brennan, Rebecca F |4 aut | |
700 | 1 | |a Simonsen, Neal R |4 aut | |
700 | 1 | |a Gastanaduy, Mariella |4 aut | |
700 | 1 | |a Zabaleta, Jovanny |4 aut | |
700 | 1 | |a Lentz, Jennifer J |4 aut | |
700 | 1 | |a Craver, Randall D |4 aut | |
700 | 1 | |a Correa, Hernan |4 aut | |
700 | 1 | |a Delgado, Alberto |4 aut | |
700 | 1 | |a Pitts, Angela L |4 aut | |
700 | 1 | |a Himel, Jane R |4 aut | |
700 | 1 | |a Udall, John N |4 aut | |
700 | 1 | |a Schmidt-Sommerfeld, Eberhard |4 aut | |
700 | 1 | |a Brown, Raynorda F |4 aut | |
700 | 1 | |a Athas, Grace B |4 aut | |
700 | 1 | |a Keats, Bronya B |4 aut | |
700 | 1 | |a Mannick, Elizabeth E |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of immune based therapies and vaccines |d London : Biomed Central, 2003 |g 2(2004), 1 vom: 14. Mai |w (DE-627)SPR029445957 |w (DE-600)2100016-5 |x 1476-8518 |7 nnns |
773 | 1 | 8 | |g volume:2 |g year:2004 |g number:1 |g day:14 |g month:05 |
856 | 4 | 0 | |u https://dx.doi.org/10.1186/1476-8518-2-6 |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 2 |j 2004 |e 1 |b 14 |c 05 |